M. Grant Kels - 03 Feb 2026 Form 3 Insider Report for Veradermics, Inc (MANE)

Role
Director
Signature
/s/ Michael Greco, Attorney-in-Fact
Issuer symbol
MANE
Transactions as of
03 Feb 2026
Net transactions value
$0
Form type
3
Filing time
03 Feb 2026, 21:06:12 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Grant-Kels Jane M. Director C/O VERADERMICS, INCORPORATED, 470 JAMES ST., NEW HAVEN /s/ Michael Greco, Attorney-in-Fact 03 Feb 2026 0002108622

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MANE Series A Convertible Preferred Stock 03 Feb 2026 Common Stock 2,455 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series A Convertible Preferred Stock is convertible into shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock"), on a 10.067-for-1 basis and has no expiration date. The Series A Convertible Preferred Stock will automatically convert into Common Stock immediately prior to the closing of the Issuer's initial public offering.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney